Brief: Keros Therapeutics Filed Prospectus Supplement To Co's Shelf Registration Statement For Issuance & Sale Of Up To $350 Mln Shares Of Common Stock
17/06/2024 23:36
June 17 (Reuters) - Keros Therapeutics Inc KROS.O :
* KEROS THERAPEUTICS:FILED PROSPECTUS SUPPLEMENT TO CO'S
SHELF
REGISTRATION STATEMENT FOR ISSUANCE & SALE OF UP TO $350 MILLION
SHARES OF COMMON STOCK
Source text for Eikon: ID:n0001664710-24-000059
Further company coverage: KROS.O
Recent news on Keros Therapeutics
See all newsBrief: Keros Therapeutics May Offer Up To $350 Million Of Securities - SEC Filing
Keros Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Keros Therapeutics Q2 net loss narrows on lower expenses
Brief: Keros Therapeutics - Keith Regnante Resigns As CFO
Keros Therapeutics posts Q1 net loss as license revenue drops